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Objective: Berries are a rich source of anthocyanins, and clinical data suggest that a polyphenol-rich diet
may exert health-promoting effects by reducing oxidative stress. The aim of this study was to elucidate the
effects of dietary supplementation with Delphinol (trademark owned by MNL Chile) standardized maqui berry
(Aristotelia chilensis) extract on products of lipid peroxidation in healthy, overweight, and smoker subjects.
Methods: In a double-blind, placebo-controlled design, 42 participants (age 45–65 years) consumed in
random order either a standardized extract of maqui berry (162 mg anthocyanins) or a matched placebo, given
3 times daily for 4 weeks. The samples were collected at baseline, after the end of the supplementation, and
40 days after the end of the study. Primary outcome was the measure of oxidized low-density lipoprotein (Ox-
LDL) and F2-isoprostanes in plasma and urine, respectively. Secondary outcomes included anthropometric
measures, blood pressure, and lipid profile.
Results: Delphinol supplementation was associated with reduced levels of Ox-LDL in the anthocyanin group
compared to baseline (p < 0.05). There was also a decrease in urinary F2-isoprostanes (8-iso-prostaglandin F2a)
at 4 weeks versus baseline in the Delphinol-supplemented group (p < 0.05). However, no differences in primary
outcomes were evident at 40 days of follow-up. In the fourth week of the intervention, no significant differences
were noted for anthropometric characteristics, ambulatory blood pressure, and lipid profile.
Conclusions: Our observations suggest that dietary interventions with maqui berry extract may improve
oxidative status (Ox-LDL and F2-isoprostanes) in healthy adults, overweight adults, and adult smokers.
INTRODUCTION
Growing clinical studies suggest that the consumption of
polyphenol-rich foods or polyphenol extracts may attenuate
oxidative stress and chronic inflammatory status associated
with noncommunicable diseases (NCDs) [1,2]. Polyphenols
are a multitude of bioactive compounds that typically occur
in plant-based foods. Among polyphenols, anthocyanins, a
large group belonging to the flavonoid family, have shown
to modulate a variety of biochemical/signaling pathways
involved in promoting beneficial properties, including vas-
culoprotective effects, cognitive enhancement, improvement
in muscular performance, and anticancer activities [3–6].
Anthocyanins, glycosides of anthocyanidins, are responsible
for the colors displayed by many frutis and are widely dis-
tributed in berries. These natural nontoxic pigments are
water-soluble compounds and divided into 6 classes: malvi-
din, delphinidin, petunidin, pelargonidin, cyanidin, and peo-
nidin [7]. The position and number of the hydroxyl and
methyl groups in the skeleton are crucial for the radical
scavenging activities of anthocyanins, and delphinidin con-
taining 3 hydroxylation in the B ring showed the highest
antioxidant activity [7,8]. Although in vitro evidence
strongly supports a role of anthocyanins in the modulation
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of well-defined molecular targets considered to be useful for
the prevention of NCDs [9–11], the few human intervention
studies offer conflicting and inconclusive results [12–14].
Because berry composition depends on genetic, seasonal,
and postharvest factors, interspecies variation in anthocyanin
content and different metabolic fates in human metabolism
may partially explain the variability in clinical study results.
Aristotelia chilensis (Molina) Stuntz, also known as maqui,
is a plant of the Elaeocarpaceae family that grows in south-
ern Chile (Valdivian temperate rain forest). In the traditional
native herbal medicine, maqui berry juices have long been
used for medicinal purposes, and several studies showed a
peculiar phytochemical composition of maqui berry with
high anthocyanin content (137.6 § 0.4 mg/100 g fresh
weight) and a relatively high percentage constituted by del-
phinidin (34% of total anthocyanins) [15,16]. Oxidative
stress and redox state unbalance are common underlying
mechanisms of several NCDs [17], and anthocyanins may
represent a relevant nutritional approach to prevent oxida-
tive modification of proteins and lipids. Therefore, the aim
of this short-term dietary intervention trial was to assess the
antioxidant effects of an anthocyanin-rich extract in healthy,
overweight, and smoker subjects.
METHODS
Subjects
Fifty overweight volunteer smokers were recruited from
the Inter-University Consortium “SannioTech”, Benevento,
Italy. The participants were enrolled into this clinical trial
(recruiting and follow-up) between January 2014 and April
2014. This study was approved by the local ethics committee
(Independent Ethics Committee of the Hospital “Gaetano
Rummo” Benevento ASL BN 1 clinical protocol no. R.F.
Rev1-10292014). All investigated subjects gave their
informed written consent. All procedures were in accordance
with institutional guidelines and were carried out in compli-
ance with the Declaration of Helsinki. The health status of the
participants was assessed and they were selected according to
the following inclusion criteria: light smokers (<1 pack per
day), inclusive age 45–65 years, good general health, and
body mass index between 25 and 30 kg/m2. Table 1 shows the
baseline characteristics of the participants. None of the sub-
jects had a history of chronic diseases. Exclusion criteria
included individuals who were taking anti-inflammatory
drugs, cardiovascular medications, lipid-altering drugs, and
hormone replacement therapy. We also excluded individuals
engaged in vigorous exercise (>2 £ 30 min/week), vegeta-
rians, and people who routinely took multivitamins or herbal
supplements. The participants were instructed to maintain
their usual dietary intakes.
Intervention Study Design
The study was a randomized, double-blind, placebo-con-
trolled trial with a 40-day follow-up period. According to the
specific inclusion criteria, 42 subjects were deemed eligible for
the study (Fig. 1). The subjects were randomly assigned to
either the anthocyanin group (n D 16; 11 men and 5 women) or
the placebo group (n D 26; 18 men and 8 women). Investiga-
tors and participants were blinded to anthocyanin group iden-
tity until after completion of the data analysis. The treatment
period lasted for 4 weeks and the anthocyanin group was
instructed to consume 3 capsules of 150 mg standardized
maqui berry extract containing 54 mg of anthocyanins (Enervit
S.p.A, Milano, Italy) daily, for a total intake of 162 mg antho-
cyanins/day. The placebo group received identical placebo
capsules 3 times daily for 4 weeks. The samples were col-
lected at baseline, at the end of the intervention period, and
40 days after the end of the treatment. All subjects declared
that they did not change their diets during the course of the
Table 1. Anthropometric Characteristics and Blood Lipid Profile from Baseline to Follow-upa
Placebo (n D 16) Delphinol Treatment (n D 26)
Baseline 4 weeks Follow up Baseline 4 weeks Follow up P
Weight (kg) 79.5 6¼ 14.8 79.5 6¼ 14.9 79.6 6¼ 14 8 78.8 6¼ 14.3 79.3 6¼ 14.4 79.7 6¼ 14.1 NS
BMI (kg/m2) 28.5 6¼ 4.7 28.3 6¼ 4.6 28.2 6¼ 4.8 28.9 6¼ 4.1 29.5 6¼ 4.9 29.9 6¼ 4.7 NS
Waist (cm) 100.6 6¼ 9.1 100.3 6¼ 9.3 100.4 6¼ 9.3 99.7 6¼ 9.5 100.3 6¼ 9 1 98.2 6¼ 9.7 NS
SBP(mm Hg) 128.5 6¼ 22.2 129.1 6¼ 23.1 128.7 6¼ 20.5 127.8 6¼ 21.2 130.2 6¼ 22.2 129.8 6¼ 21.6 NS
DBP(mm Hg) 81.4 6¼ 12.1 81.3 6¼ 13.5 79.8 6¼ 14.3 82.2 6¼ 12.5 82.8 6¼ 12.6 83.5 6¼ 13.6 NS
GG (mmol/L) 1.35 6¼ 0.98 8.37 6¼ 0.56 1.33 6¼ 0.78 1.33 6¼ 0.66 1.29 6¼ 0.86 1. 30 6¼ 0.94 NS
TC (mmol/L) 4.35 6¼ 0.45 4.32 6¼ 0 66 4.36 6¼ 0.84 4.34 6¼ 0 55 4.33 6¼ 0.97 4.33 6¼ 0.83 NS
HDLc (mmol/L) 1.16 6¼ 0.31 1.15 6¼ 0.27 1.15 6¼ 0.76 1 16 6¼ 0.35 1. 17 6¼ 0.47 1 16 6¼ 0.32 NS
LDLc (mmol/L) 2.75 6¼ 0.88 2.73 6¼ 0.76 2.73 6¼ 0.93 2.74 6¼ 0.97 2.72 6¼ 0.75 2.72 6¼ 0.79 NS
BMI D body mass index, SBP D systolic blood pressure, DBP D diastolic blood pressure, TG D triglycerides, TC D total cholesterol, HDLc D high-density lipoprotein
cholesterol, LDLc D low-density lipoprotein cholesterol.
aAll values are mean § SD. There were no significant differences. Significance was set at p > 0.05.
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study and they attended our medical facility every month to
assess clinical conditions and adherence to the protocol.
Material
The anthocyanin and placebo capsules used in this trial
were identically packaged. According to the manufacturer
(Enervit S.p.A), Delphinol maqui berry extract is standardized
to contain approximately 35% of total anthocyanins and 28%
of total delphinidins. These capsules also contained maltodex-
trin to maintain stability, as well as traces of dietary minerals,
such as calcium and magnesium. Placebo capsules consisted of
maltodextrin. The dose of anthocyanins was determined based
on 2 recent human studies. The first clinical investigation per-
formed by Karlsen et al. [11] found that daily intake of
320 mg anthocyanins is safe and effective against inflamma-
tory response. The second study reported that the administra-
tion of 200 mg Delphinol has no side effects [18].
Biochemical Analyses
Samples were collected in EDTA-containing vials that were
immediately stored at ¡80C until analysis. Triglycerides,
total cholesterol, high-density lipoprotein cholesterol (HDLc),
and low-density lipoprotein cholesterol (LDLc) were measured
using colorimetric enzymatic tests (Thermo Scientific, Wal-
tham, MA). The plasma concentration of oxidized LDL (Ox-
LDL) was measured by a sandwich enzyme-linked immuno-
sorbent assay methodusing a commercially available kit
(Immundiagnostik AG, Bensheim, Germany) described previ-
ously by Licastro et al. [19].
Determination of Urinary F2-Isoprostanes
According to the study design, sampling of morning urine
was performed at the beginning (baseline), at 4 weeks, and at
the end of follow-up. Urine samples were collected into 10-ml
plastic centrifuge tubes (FL Medical, Torreglia, Italy) and
stored at ¡80C until analysis. 8-iso-Prostaglandin (PG) F2a
in urine was determined by liquid chromatography–tandem
mass spectrometry (LC-MS/MS) as previously described by
Yan et al. [20] with slight modifications. Briefly, 1 mL urine
was spiked with deuterated internal standards (8-iso-PGF2a-
d4; 20 ng/ml) and the supernatant was loaded on a C18 solid-
phase extraction cartridge (SPE C18; Supelco, Bellefonte, PA)
that had been preconditioned with 5 ml of methanol and equili-
brated with 5 ml of water. The cartridge was washed succes-
sively with 5 ml of water, 5 ml ethanol : water 5:95, and 1 ml
of hexane. SPE C18 cartridges were eluted with 2 ml of ethyl
acetate and dried under a stream of nitrogen. After adding 50
ml of acetonitrile : water 80:20 to the eluent, the samples were
analyzed using an LCMS-8040 LC-MS/MS system (Shimadzu,
Kyoto, Japan). Data are presented as picograms of 8-iso-
PGF2a per milligram of urinary creatinine. Creatinine in urine
was measured with a spectrophotometric method using a clini-
cal chemistry analyzer (BPC Biosed, Castelnuovo di Porto,
Italy). Overall recovery of the method was over 80%.
Statistical Analysis
The data are expressed as mean § SD. The differences
between groups were evaluated by t test for independent sam-
ples and by analysis of variance. In each group, differences
Fig. 1. Flowchart of enrollment, intervention allocation, and follow-up.
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from baseline were evaluated by t test for paired samples. Sta-
tistical significance was assigned as p < 0.05. Statistical analy-
ses were performed using R statistical Software (Revolution
Analytics, Palo Alto, CA).
RESULTS
From the initial 50 subjects enrolled in the study, 42 met the
inclusion criteria and were randomized into the trial (Fig. 1).
The participants were in general healthy and no adverse events
resulting from the consumption of either the placebo or antho-
cyanin capsules were observed throughout the intervention.
Baseline characteristics of the participants are detailed in
Table 1. From baseline to follow-up, there were no statistical
differences among the different groups in anthropometric
measurements, blood pressure, and lipid profile (except Ox-
LDL; Table 1). Although total cholesterol, triglycerides,
HDLc, and LDLc levels were unaffected by Delphinol treat-
ment, after 4 weeks of intervention, maqui berry extract sup-
plementation resulted in decreased plasma concentration of
Ox-LDL in the Delphinol group compared to baseline (Fig. 2,
p < 0.05). However, no significant differences in plasma con-
centration of Ox-LDL were observed between the placebo and
supplemented groups after the 40 days of follow-up compared
to the levels of Ox-LDL at baseline and at the end of the inter-
vention period. Taken together, these results show that an
anthocyanin-rich diet may reduce oxidative modifications of
LDL in overweight and smoker subjects. In an effort to further
explore the antioxidant impact of Delphinol supplementation,
we examined the urinary excretion of 8-iso-PGF2a. As shown
in Fig. 3, 8-iso-PGF2a did not differ at baseline between the
placebo and Delphinol groups. Following 4 weeks of Delphi-
nol consumption, a significant decrease in urinary 8-iso-
PGF2a levels was observed in the supplemented group (Fig. 3,
p < 0.05). In contrast, at the end of follow-up period, no statis-
tically significant changes were noted in 8-iso-PGF2a concen-
trations in either group. These data raise the possibility that
Delphinol supplementation may be an effective nutritional
strategy to counteract oxidative challenge.
DISCUSSION
An extensive body of evidence suggests that oxidative
stress and resulting lipid peroxidation may be crucial in the
pathophysiology of several diseases [21–23]. The beneficial
effects of berry fruits on oxidative stress have been investi-
gated in different experimental in vitro and in vivo studies
[24]. Berry anthocyanins have attracted scientific attention for
their antioxidant and anti-inflammatory activities [25] and in
this context it should be pointed out that maqui berries have
higher anthocyanin content than other Chilean berries [26].
This study was designed to investigate whether consumption
of maqui berry extract is effective in reducing lipid peroxida-
tion products. In particular, the rationale behind this study was
to assess whether specific anthocyanin derivative(s) present in
maqui berry extract, such as delphinidin, can improve oxida-
tive status.
With regard to secondary outcomes, we observed no effect
of maqui berry supplementation on blood pressure and anthro-
pometric variables. In addition, no significant effects were seen
on total cholesterol, triglycerides, HDLc, and LDLc levels
(Table 1). These results contrast with other published studies
in which anthocyanin supplementation improved lipid panel
indices [14,27,28]. Although there is much evidence on the
lipid-lowering effects of anthocyanins, the discrepancy may be
attributed, at least partly, to different characteristics of the
enrolled subjects and diversity of anthocyanin composition and
dosage of berry extracts. However, in the current study the
decrease in concentration of Ox-LDL, after a short period of
supplementation with maqui berry extract (Fig. 2), may indi-
cate that this dietary supplement improves oxidative stress in
healthy humans. These findings are consistent with previous
Fig. 2. Change in Ox-LDL values within each group after 4 weeks of
intervention and 40 days of follow-up. Data are expressed as mean §
SD. *Significantly different from baseline at p < 0.05.
Fig. 3. Effects of Delphinol supplementation on urinary excretion of
8-iso-PGF2a in overweight smokers. Data are expressed as mean §
SD. *Significantly different from baseline at p < 0.05.
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reports indicating that diets rich in anthocyanins can reduce
Ox-LDL [29,30]. The use of urine samples (free from lipids) to
evaluate 8-iso-PGF2a levels was based on evidence from clini-
cal trials suggesting that Ox-LDL and 8-iso-PGF2a represent
different entities in the process of oxidative modification
[31,32]. Thus, the present study used 8-iso-PGF2a as a urinary
index of oxidative stress. Previous reports have shown that the
urinary excretion of 8-iso-PGF2a is enhanced under several
conditions, including cigarette smoking [33,34]. In agreement
with other antioxidant supplementation trials [35,36], we have
shown a decrease in urinary 8-iso-PGF2a in overweight smok-
ers (Fig. 3). This result suggests that the effect of Delphinol on
8-iso-PGF2a is both rapid and sustained throughout the inter-
vention. However, although anthocyanin supplementation pro-
duced a reduction in the concentration of Ox-LDL and 8-iso-
PGF2a, the values returned to baseline after 40 days of follow-
up. Taken together, these data raise the possibility that Delphi-
nol may induce a positive and transient systemic effect on oxi-
dative status. However, there are several limitations to be
acknowledged in the present study, most important of which is
the absence of a prescribed standardized diet. Therefore, the
findings must be viewed with caution and we need to confirm
the present results in the setting of a controlled feeding study.
Delphinol was consumed for a short period of time, and it
remains unclear whether the beneficial effects on oxidative
stress would persist with longer treatment. Furthermore, our
study provides no insight into the mechanism of benefit, and
additional studies are needed to define the mechanisms of these
effects. The study limitations were balanced by the placebo-
controlled design and a relatively large sample size. In conclu-
sion, our results indicate that dietary supplementation with
maqui berry extract exerts antioxidant effects in healthy, over-
weight, and smoker subjects. Overall, this study suggests a pos-
itive nutritional influence of anthocyanin on lipid peroxidation,
and this effect may be considered useful for the prevention of
diseases associated with oxidative stress.
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